X
Please Wait
Applying Filters...
01 SANOFI AVENTIS US (2)
01 TABLET, EXTENDED RELEASE;ORAL (2)
01 RX (2)
01 AMBIEN CR (2)
01 Yes (2)
Cophex 2024
Not Confirmed
Contact SupplierCophex 2024
Not Confirmed
Contact Supplier19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is ZOLPIDEM TARTRATE, with a corresponding application number 21774.
Regulatory Information RX
With a dosage strength 12.5MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2005-09-02
Therapeutic Equivalence (TE) Code AB
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is ZOLPIDEM TARTRATE, with a corresponding application number 21774.
Regulatory Information RX
With a dosage strength 6.25MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2005-09-02
Therapeutic Equivalence (TE) Code AB
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
